In partnership with
AIHealthTech Insider: Issue # 115
August 24, 2026
This week: The FDA authorized the first standalone robotic blood-draw device. Plus, AI finds clues to vaccine response, machine learning identifies possible childhood-dementia drugs, and researchers test a wearable alternative to invasive ICU blood-pressure monitoring.
Here’s what changed, in plain English.
Summaries are for education, not medical advice. Always verify locally before clinical use.
☕ Quick question before we dive in 👇
Would you let a robot draw your blood?
👇 Later in this issue: Could one emoji make remote work feel more human?
🔬 The Big Story
A Robot Can Draw Blood—Here’s What the FDA Authorized
The FDA authorized Aletta, the first standalone robotic device that can draw blood from an adult’s arm without hands-on assistance.
Image: AI-generated, AIHealthTech Insider
Developed by Vitestro, it uses near-infrared light and Doppler ultrasound to find a suitable vein. If it cannot find one, it does not proceed.
A trained phlebotomist must start each session, remain available, and check the collection tubes. One professional can supervise up to three devices.
Why it matters: Automation could reduce blood-draw delays caused by shortages of trained staff.
The honest part: Aletta is supervised and limited to outpatient settings. When it proceeded with a needle stick, FDA-reviewed data showed success rates comparable to or better than trained professionals. Device-related adverse events were uncommon and mild.
The real test will be how well it fits clinic workflows—and whether patients trust it.
New here? Get one carefully sourced AI-healthcare briefing every Monday—written in plain English, without the hype.
Sponsored
The CBD Brand that Actually Does What It Says
CBD is having a moment and CBD brands are everywhere right now. But with so many options, it can be tough to know what to look for – and which brands actually follow through on their claims.
That’s where CBDistillery sets itself apart. For the past decade, all of CBDistillery's products have been made with non-GMO, US-grown industrial hemp and with 100% clean ingredients – no corn syrup or artificial colors, flavors, preservatives or sweeteners.
They frequently introduce new and innovative products formulated to meet a variety of wellness needs and customer preferences. And every single batch of CBDistillery’s gummies, oil tinctures, topicals and softgels are tested by an independent, accredited lab to make sure what’s in the package matches what’s on the label.
Right now, CBDistillery is offering our readers a special deal: save 50% on orders of $75 or more with code AUGUST50!
⚡ Quick Hits
Image: AI-generated, AIHealthTech Insider
🔸AI found signs of vaccine readiness before vaccination
Deep learning analyzed 8,687 blood samples from 4,089 people and found antibody patterns linked to stronger or weaker COVID-19 vaccine responses.
The approach could eventually identify people who need extra doses or follow-up, but it is not ready for clinical use.
🔸Machine learning identified possible childhood-dementia drugs
Researchers used patient-derived stem cells to grow brain cells modeling Sanfilippo syndrome. A machine-learning drug screen identified at least nine repurposed compounds that reduced disease-related effects within two weeks.
The study was peer-reviewed, but the findings came from laboratory-grown cells—not patients.
🔸A wearable sensor could spare ICU patients a painful procedure
In an initial study of 28 ICU patients, a wearable AI system produced continuous blood-pressure readings that closely matched arterial-line measurements.
It could reduce bleeding, clotting, infection, and discomfort, but larger studies are needed.
Sponsored
One idea shouldn't take six rewrites to post.
Posting everywhere means rewriting one idea six times, so you post to one, or none. SureThing turns one idea into native posts for every platform.
Know someone in healthcare, medicine, or AI? Forward this to them. They can subscribe free here →
🌍 Beyond AI
Could an Emoji Help Remote Workers Stay Engaged? 👍
GitHub contributors who used an emoji in at least one post during 2018 were less likely to stop contributing the following year.
Image: AI-generated, AIHealthTech Insider
After researchers adjusted for differences between contributors, emoji use was linked to about half the dropout risk—an absolute reduction of 5.2 percentage points. The absolute difference was greatest among newer contributors.
Why it matters: Emojis cannot fix burnout, but they may make text-based communication feel warmer and more personal.
The honest part: Researchers used statistical methods to reduce bias, but this was not a randomized workplace experiment and cannot rule out every other explanation.
Sponsored
10x the context. Half the time.
Speak your prompts into ChatGPT or Claude and get detailed, paste-ready input that actually gives you useful output. Wispr Flow captures what you'd cut when typing. Free on Mac, Windows, and iPhone.
🧠 Brain in Brief
Preliminary research presented at FENS Forum 2026 used brain scans and AI to estimate “brain age.” Bilingual participants had brains that appeared around six years younger than monolingual participants. Among people who spoke four languages, the difference reached approximately 13 years.
This was an association—not proof that language learning slows brain aging. Lifestyle and social engagement may also contribute.
Stay ahead: AI Healthcare News!
This week’s pattern: AI is moving from interpreting medical information to performing routine clinical work. The real test will be whether it improves care without weakening patient trust.
Get one carefully sourced AI-healthcare briefing every Monday.
